Solventum Corporation (SOLV)

Solventum's stock has gained 13.4% over the past six months, outperforming the Health Care Select Sector SPDR Fund. In Q3 2025, Solventum reported revenues of approximately $2.1 billion and adjusted EPS of $1.50, raising its full-year 2025 EPS guidance. Despite better-than-expected financials, Solventum's stock prices dropped 4.4% after the release of its Q4 2025 results due to increased cost of sales and lower non-GAAP net income. In September 2025, Solventum completed the divestiture of its purification and filtration business, using proceeds to repay debt and leading to an upgrade of its credit ratings. As of early February 2026, the stock has decreased by 7.20% in the past month, with an all-time high closing price of $86.14 on January 9, 2026.

While specific detailed information on demand seasonality for all of Solventum's products and services is limited, there is a mention of "normal manufacturing seasonality" contributing to a year-over-year decline in gross margin in Q1 FY2025, suggesting some seasonal fluctuations.

Solventum Corporation is an independent healthcare company spun off from 3M in April 2024. It operates in the medical instruments and apparatus industry with three segments: Medsurg, Dental Solutions, and Health Information Systems. Previously, it had a Purification and Filtration segment, which was divested in September 2025. The Medsurg segment offers solutions like wound therapy and surgical supplies. The Dental Solutions segment provides dental and orthodontic products. The Health Information Systems segment delivers software solutions and services for healthcare systems.

Solventum Corporation has a strong global presence, serving hospitals, clinics, dental practices, and pharmacies worldwide. The company also has a global manufacturing footprint.

Solventum emphasizes its commitment to quality, innovation, and customer satisfaction, leveraging over 70 years of healthcare innovation. In its first year as a publicly traded company, Solventum donated over $1.2 million to community partners, launched a global employee assistance program, and pledged to source 100% renewable electricity by 2030. Potential risks to the company's reputation include damage to its brands, risks from acquisitions, divestitures, and other strategic events, and business dealings involving third-party partners.

Solventum Corporation's stock ownership is a mix of institutional, insider, and public/individual investors. Institutional investors own approximately 40.95% of the company's stock. Insiders own about 14.88% of the stock. Public companies and individual investors own approximately 44.17% of the stock. Major institutional owners include 3M Company, The Vanguard Group, Inc., and BlackRock, Inc.